Retro Report: Lives and Profits in the Balance: The High Stakes of Medical Patents

Sunday, December 11, 2016 - 22:11 in Mathematics & Economics

Tensions inherent to drug pricing pit affordability against the need to recoup investment in research, raising questions about how much of the cost patients should have to bear.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net